<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Saudi Med</journal-id>
      <journal-id journal-id-type="publisher-id">ASM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Saudi Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0256-4947</issn>
      <issn pub-type="epub">0975-4466</issn>
      <publisher>
        <publisher-name>Medknow Publications</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20103962</article-id>
      <article-id pub-id-type="pmc">2850186</article-id>
      <article-id pub-id-type="publisher-id">ASM-30-70</article-id>
      <article-id pub-id-type="doi">10.4103/0256-4947.59381</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Combined occurrence of diabetes mellitus and retinitis pigmentosa</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Adsani</surname>
            <given-names>Afaf</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gader</surname>
            <given-names>Fadl Abdel</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001"/>
        </contrib>
      </contrib-group>
      <aff id="AF0001">From the Department of Medicine, Al-Sabah Hospital, Kuwait</aff>
      <author-notes>
        <corresp id="cor1">Correspondence: Dr. Afaf Al-Adsani &#xB7; Department of Medicine, Al-Sabah Hospital, PO Box 4078 Safat, 13041, Sualibikhat, Kuwait 90801, Kuwait, &#xB7; T: +965-2-481-3062 F: +965-2-488-3418 &#xB7; <email xlink:href="amsaladsani@yahoo.com">amsaladsani@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2010</year>
      </pub-date>
      <volume>30</volume>
      <issue>1</issue>
      <fpage>70</fpage>
      <lpage>75</lpage>
      <history>
        <date date-type="accepted">
          <month>5</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Annals of Saudi Medicine</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The combined occurrence of diabetes mellitus (DM) and retinitis pigmentosa (RP) is rare. It has been reported in the form of four different syndromes that are inherited in an autosomal recessive fashion. We describe two cases of DM and RP occurring together. The first case was a 35-year-old male who presented with insulin-treated diabetes, obesity, hypertension, polydactyly, normal cognitive functions, an ataxic gait, blindness secondary to RP, dyslipidemia, impaired renal function, and multiple renal cysts. He was diagnosed clinically as having Bardet-Biedl syndrome. The second case was a 34-year-old male who presented with insulin-resistant diabetes, hypertension, blindness secondary to RP, deafness, normal cognitive functions, primary infertility, renal, and liver impairment. He was diagnosed clinically as having Alstr&#xF6;m syndrome. Because of overlapping clinical manifestations and the cost and time involved in genetic studies, clinical criteria can be used for diagnosis and as a guide for genetic mapping in these patients.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Although diabetes mellitus (DM) and retinitis pigmentosa (RP) are common and occur independently, the combination of both conditions is rarely seen in clinical practice. Four syndromes have been reported<xref ref-type="bibr" rid="CIT2">2</xref><xref ref-type="bibr" rid="CIT8">8</xref><xref ref-type="bibr" rid="CIT15">15</xref><xref ref-type="bibr" rid="CIT20">20</xref> describing the combination of both conditions that were coexistent with other manifestations such as obesity, deafness, hypogonadism, renal abnormalities, and/or mental retardation. The inheritance of these syndromes is autosomal recessive. Diagnosis can be done clinically based on primary and secondary features, but molecular genetic testing may be needed for accurate diagnosis and genetic counselling. In this report, we describe two cases who presented with diabetes and retinitis pigmentosa along with other manifestations. In both cases, the diagnosis was established on the basis of clinical findings. The first case was diagnosed as Bardet-Biedl syndrome based on the clinical presentation of DM with RP along with obesity, polydactyly, renal cortical cysts, and ataxic gait, whereas the second case was diagnosed as Alstr&#xF6;m syndrome based on the clinical presentation of RP and insulin-resistant diabetes, deafness, hepatic dysfunction, renal impairment, and hypogonadism. We also reviewed the literature summarizing the clinical manifestations and the mode of inheritance of each syndrome.</p>
    <sec id="sec1-1">
      <title>CASE 1</title>
      <p>A 35 year-old Iraqi male was referred to our diabetes clinic for insulin-treated DM, impaired renal function with a serum creatinine level of 188 mmol/L (normal reference range is 45-105 mmol/L), gross proteinuria of 2.7 g/day, and a fasting blood sugar level of 13.7 mmol/L (RR is 3.9-6.1 mmol/L). The patient had been diagnosed with Laurene-Moon-Biedl syndrome since 1990, with a history of night blindness and gradual visual deterioration since childhood. He was ultimately registered as being blind in 1999, when he was also found to be diabetic. He was hypertensive and dyslipidemic; his parents were first cousins. Clinical examination revealed a weight of 120 kg, a height of 180 cm, a body mass index (BMI) of 36.3 kg/m<sup>2</sup>, and a BP of 140/100 mm Hg. He had polydactyly of the left hand and both feet (<xref ref-type="fig" rid="F0001">Figure 1</xref>). Examination of the heart, abdomen, and chest did not reveal any abnormalities. Neurologically, he had normal cognitive functions, but had an ataxic gait and diminished vibration and pain sensation over both the lower limbs with intact peripheral pulsation. Fundus examination revealed retinitis pigmentosa and optic atrophy (<xref ref-type="fig" rid="F0002">Figure 2</xref>, Panel a). His biochemical profile showed an elevated triglyceride level at 3.54 mmol/L (RR is 0-2.2 mmol/L) and an LDL cholesterol level of 2.28 mmol/L (RR is 3.9-5.2 mmol/L). Serum creatinine level gradually rose to 290 mmol/L; the C-peptide level was 137 pmol/L (RR is 256-1325 pmol/L). Abdominal ultrasound showed multiple cortical renal cysts with multiple stones, mild hepatomegaly, and multiple gall bladder stones. Molecular genetic testing was not available. His HbA<sub>1c</sub> level of 6.2% was controlled with insulin. He was diagnosed clinically as having Bardet-Biedl syndrome based on the clinical presentation of DM with retinitis pigmentosa, obesity, polydactyly, renal cortical cysts, and an ataxic gait.</p>
      <fig id="F0001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Polydactyly of left hand (a) and both feet (b).</p>
        </caption>
        <graphic xlink:href="ASM-30-70-g001"/>
      </fig>
    </sec>
    <sec id="sec1-2">
      <title>CASE 2</title>
      <p>34-year-old Kuwaiti male was referred to our diabetes clinic for insulin-treated diabetes and uncontrolled hyperglycemia. A detailed history revealed that diabetes was diagnosed five years ago along with a diagnosis of hypertension. He begin having gradual visual deterioration and night blindness at the age of six years and was registered as being blind at the age of nine years. His parents were third cousins and his sister, who was also diabetic and blind, had died of renal failure. He had been married for one year; primary infertility was also observed. Clinical examination revealed a weight of 71 kg, a height of 158 cm, a BMI of 28.4 kg/m<sup>2</sup>, and a blood pressure of 120/80 mm Hg. Fundus examination revealed retinitis pigmentosa along with optic atrophy (<xref ref-type="fig" rid="F0002">Figure 2</xref>, Panel b). Systemic examination did not reveal any remarkable findings, instead showing intact peripheral sensation and pulsation. Investigations revealed a fasting blood glucose level of 18.1 mmol/L, HbA<sub>1c</sub> of 15.1%, and a C-peptide level of 2247 pmol/L (normal range: 256-1325 pmol/L). The triglyceride level was 4.06 mmol/L, LDL cholesterol level was 4.25 mmol/L, and HDL cholesterol level was 1.07 mmol/L (RR is 1.01-2.94 mmol/L). His serum creatinine level was 96 &#x3BC;mol/L and microalbuminurea testing yielded 457 mg/day (RR is &lt; 20 mg/day). The alkaline phosphatase level was 155 U/L ((RR is 50-136 U/L)) and ALT 63 U/L (RR is 30-65 U/L). Thyroid function tests were normal. The audiogram demonstrated sensineural deafness. Endocrinological evaluation revealed azospermia and biopsy showed only Sertoli cells. Genetic testing yielded 46XY, but no chromosomal mutations, deletions or other abnormalities could be detected. Molecular genetic testing was not available. His diabetes was gradually controlled with increasing doses of insulin and metformin given at doses of up to 2 g per day along with statins. This resulted in better glycemic control and significant improvement in the lipid profile and HbA<sub>1c</sub> level of 9.7%. Subsequently, metformin was discontinued because of elevated liver enzyme levels. Abdominal ultrasound revealed a fatty liver and liver biopsy revealed nonalcoholic steatohepatitis. Screening for hepatitis viruses B and C as well as for ANCA and ANA antibodies was negative. Following improvement of the liver profile, rosiglitazone was prescribed along with insulin, and HbA<sub>1c</sub> improved to 8.8%. Later, the renal profile was found to be impaired and ultrasound examination of the liver showed cirrhotic changes. The serum creatinine level remained stable at 120 &#x3BC;mol/L, and he declined renal biopsy. Rosiglitazone was discontinued and the insulin dose increased up to 245 units per day. His blood sugar levels were still out of control and he was not adherent to his controlled diet regimen. He was diagnosed clinically as having Alstr&#xF6;m syndrome based on his clinical presentation of insulin-resistant diabetes with retinitis pigmentosa, deafness, hepatic dysfunction, renal impairment, and hypogonadism.</p>
      <fig id="F0002" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Retinitis pigmentosa: a speckling of the retinal pigment epithelium with bone-spicule pigmentation, optic nerve pallor, and retinal arteriolar attenuation.</p>
        </caption>
        <graphic xlink:href="ASM-30-70-g002"/>
      </fig>
    </sec>
    <sec sec-type="" id="sec1-3">
      <title>DISCUSSION</title>
      <p>RP is a group of inherited disorders characterized by progressive peripheral vision loss and night vision difficulties that can lead to central vision loss. It is caused by molecular defects in more than 100 different genes.<xref ref-type="bibr" rid="CIT1">1</xref> RP is most commonly found in isolation, but it can be associated with several systemic diseases such as deafness, neurological disorders, cardiovascular anomalies, renal manifestations, obesity, and diabetes. Four rare syndromes have been reported as describing the combination of RP and DM. These include Bardet-Biedl syndrome, Alstr&#xF6;m syndrome, Kearns-Sayre syndrome, and rarely, Wolfram syndrome. <xref ref-type="table" rid="T0001">Table 1</xref> summarizes the mode of inheritance, the affected genes, and the clinical manifestations of each syndrome.</p>
      <table-wrap id="T0001" position="float">
        <label>Table 1</label>
        <caption>
          <p>Syndromes associated with diabetes mellitus and retinitis pigmentosa</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">Bardet-Biedl</th>
              <th align="left" rowspan="1" colspan="1">Alstr&#xF6;m</th>
              <th align="left" rowspan="1" colspan="1">Kearns-Sayre</th>
              <th align="left" rowspan="1" colspan="1">Wolfram (DIDMOAD)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Mode of inheritance</td>
              <td align="left" rowspan="1" colspan="1">Autosomal recessive</td>
              <td align="left" rowspan="1" colspan="1">Autosomal recessive</td>
              <td align="left" rowspan="1" colspan="1">Mitochondrial disease</td>
              <td align="left" rowspan="1" colspan="1">Autosomal recessive</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Genes involved</td>
              <td align="left" rowspan="1" colspan="1">12 genes, mostly BBS1, BBS2, BBS6, BBS10, MKKS</td>
              <td align="left" rowspan="1" colspan="1">ALMS1 gene, 81 mutations so far</td>
              <td align="left" rowspan="1" colspan="1">mt-DNA mutations/deletions</td>
              <td align="left" rowspan="1" colspan="1">WFS1 gene mutation</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Clinical features</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Diabetes mellitus</td>
              <td align="left" rowspan="1" colspan="1">Noninsulin-dependent</td>
              <td align="left" rowspan="1" colspan="1">Insulin-resistant</td>
              <td align="left" rowspan="1" colspan="1">Insulin-dependent</td>
              <td align="left" rowspan="1" colspan="1">Type 1 nonautoimmune</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Retinitis pigmentosa</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Childhood obesity</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Mental retardation</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Polydactyly</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Infertility/hypogonadism</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Sensorineural deafness</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">+</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Renal disease</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Hepatic involvement</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Short stature</td>
              <td align="left" rowspan="1" colspan="1">&#xB1;</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Acanthosis nigricans</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">+</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Cardiac disease</td>
              <td align="left" rowspan="1" colspan="1">Congenital detects</td>
              <td align="left" rowspan="1" colspan="1">Cardiomyopathy</td>
              <td align="left" rowspan="1" colspan="1">Heart block</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Neurologic disease</td>
              <td align="left" rowspan="1" colspan="1">Ataxia, incoordination</td>
              <td align="left" rowspan="1" colspan="1">Absence seizures, sleep disorders</td>
              <td align="left" rowspan="1" colspan="1">External ophthalmoplegia</td>
              <td align="left" rowspan="1" colspan="1">Ataxia, brain stem disorder, nystagmus, sleep apnea</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Other features</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
              <td align="left" rowspan="1" colspan="1">Hypothyroidism, hypertension</td>
              <td align="left" rowspan="1" colspan="1">Hypothyroidism Hypomagnesemia, Hyperaldosteronelism</td>
              <td align="left" rowspan="1" colspan="1">&#x2212;</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Prognosis</td>
              <td align="left" rowspan="1" colspan="1">Death is usually due to renal failure and 25% die by the age of 44 years</td>
              <td align="left" rowspan="1" colspan="1">Death is usually due to renal failure and patients rarely live longer than 40 years.</td>
              <td align="left" rowspan="1" colspan="1">Death is usually from cardiac disorders and death is common in the third or fourth decade of life</td>
              <td align="left" rowspan="1" colspan="1">Death is usually due to respiratory and renal failure and median age at death is 30 years</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The term, &#x201C;Laurence-Moon-Bardet-Biedl&#x201D; was coined in 1925.<xref ref-type="bibr" rid="CIT2">2</xref> In 1982, Laurence-Moon and Bardet-Biedl syndromes began to be considered as two separate syndromes due to the essential differences between them.<xref ref-type="bibr" rid="CIT3">3</xref> The Laurence-Moon syndrome is considered to be composed of retinitis pigmentosa, obesity, hypogonadism and spastic paraparesis without polydactyly, and DM. However, recently, and because mutations have now been detected in Bardet-Biedl syndrome genes in families conforming to the diagnosis of the Laurence-Moon syndrome, some authorities do not believe in this distinction and consider the two to be one syndrome under the label of Bardet-Biedl syndrome (BBS). The prevalence of BBS ranges from one in 13 500 in a consanguineous population, to one in 160 000 in nonconsanguineous populations. It is usually inherited in an autosomal recessive manner.<xref ref-type="bibr" rid="CIT2">2</xref> It is clinically characterized by: (i) cone-rod dystrophy (100%) that usually affects the vision in the first decade; the patients will be legally blind by the second decade, (ii) obesity (72-96%), which usually begins within the first year, (iii) postaxial polydactyly (58-69%), (iv) renal dysfunction (46%), (v) cognitive impairment, (vi) male hypogonadotrophyic hypogonadism, and (vii) complex female genitourinary malformations. All above manifestations are postulated to be due to defects in the cilia. Because of the wide range of clinical variability observed within BBS, the diagnosis is established on the basis of clinical findings. Clinical diagnosis can be made with four primary or three primary and two secondary features as shown <xref ref-type="table" rid="T0002">Table 2</xref>.<xref ref-type="bibr" rid="CIT2">2</xref> Diabetes mellitus is diagnosed in 32-45% of cases with BBS.<xref ref-type="bibr" rid="CIT3">3</xref><xref ref-type="bibr" rid="CIT4">4</xref> It is usually noninsulin-dependent diabetes but is occasionally insulin-dependent, and is treated as usual in the general population.<xref ref-type="bibr" rid="CIT2">2</xref><xref ref-type="bibr" rid="CIT4">4</xref> Renal disease is a major cause of morbidity and mortality in BBS patients and 25% die by the age of 44 years.<xref ref-type="bibr" rid="CIT4">4</xref> Molecular genetic studies found 14 genes to be associated with BBS.<xref ref-type="bibr" rid="CIT2">2</xref><xref ref-type="bibr" rid="CIT5">5</xref><xref ref-type="bibr" rid="CIT6">6</xref><xref ref-type="bibr" rid="CIT7">7</xref> <xref ref-type="table" rid="T0003">Table 3</xref> summarizes the genes identified so far and the percentage of the most common causative mutations and exons. However, approximately 20% to 30% of patients do not have identifiable mutations, suggesting that more BBS cases are yet to be identified. Some genotype/phenotype correlations have been reported (<xref ref-type="table" rid="T0003">Table 3</xref>) although most of the studies did not confirm these correlations.</p>
      <table-wrap id="T0002" position="float">
        <label>Table 2</label>
        <caption>
          <p>Diagnostic criteria for Alstr&#xF6;m syndrome and Bardet-Biedl syndrome.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">Major criteria/Primary features</th>
              <th align="left" rowspan="1" colspan="1">Minor criteria/Secondary features</th>
              <th align="left" rowspan="1" colspan="1">Other supportive evidence</th>
              <th align="left" rowspan="1" colspan="1">Diagnosis</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Bardet-Biedl syndrome</td>
              <td align="left" rowspan="1" colspan="1">Cone-rod dystrophy</td>
              <td align="left" rowspan="1" colspan="1">Speech disorder/delay</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Postaxial polydactyly</td>
              <td align="left" rowspan="1" colspan="1">Strabismus/cataracts/astigmatism</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Truncal obesity</td>
              <td align="left" rowspan="1" colspan="1">Brachydactyly/syndactyly</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Learning disabilities</td>
              <td align="left" rowspan="1" colspan="1">Developmental delay</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Hypogonadism in males or genital abnormalities in females</td>
              <td align="left" rowspan="1" colspan="1">Polyuria/polydipsia (nephrogenic diabetes insipidus)</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Renal anomalies</td>
              <td align="left" rowspan="1" colspan="1">Ataxia/poor coordination/imbalance</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">4 major criteria OR 3 major + 2 minor criteria</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Mild hypertonia (especially lower limbs)</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Diabetes mellitus</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Dental crowding/hypodontia/small dental roots/high-arched palate</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Cardiovascular anomalies</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Hepatic involvement</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="5" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Alstr&#xF6;m syndrome</td>
              <td align="left" rowspan="1" colspan="1">ALMS 1 mutation in 1 allele and/or family history of Alstr&#xF6;m syndrome</td>
              <td align="left" rowspan="1" colspan="1">Obesity and/or insulin resistance and/or type 2 diabetes</td>
              <td align="left" rowspan="1" colspan="1">Recurrent pulmonary infections</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Vision (legal blindness, history of nystagmus in infancy/childhood, cone and rod dystrophy by electroretinogram</td>
              <td align="left" rowspan="1" colspan="1">History of dilated cardiomyopathy/congestive heart failure</td>
              <td align="left" rowspan="1" colspan="1">Normal digits</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Hearing loss</td>
              <td align="left" rowspan="1" colspan="1">History of developmental delay</td>
              <td align="left" rowspan="1" colspan="1">2 major + 2 minor criteria</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Hepatic dysfunction</td>
              <td align="left" rowspan="1" colspan="1">Hyperlipidemia</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Renal failure</td>
              <td align="left" rowspan="1" colspan="1">Scoliosis</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Short stature</td>
              <td align="left" rowspan="1" colspan="1">Flat wide feet</td>
              <td align="left" rowspan="1" colspan="1">OR</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Males &#x2013; hypogonadism</td>
              <td align="left" rowspan="1" colspan="1">Hypothyroidism</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Females &#x2013; irregular menses and/or hyperandrogenism</td>
              <td align="left" rowspan="1" colspan="1">Hypertension</td>
              <td align="left" rowspan="1" colspan="1">1 major + 4 minor criteria</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Growth hormone deficiency Alopecia</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Recurrent urinary tract infections or urinary dysfunction</td>
              <td rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T0003" position="float">
        <label>Table 3</label>
        <caption>
          <p>Known genes and gene mutations in Bardet-Biedl syndrome and Alstr&#xF6;m syndrome.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">Causative genes identified</th>
              <th align="left" rowspan="1" colspan="1">Mutations (%)</th>
              <th align="left" rowspan="1" colspan="1">Exon (%)</th>
              <th align="left" rowspan="1" colspan="1">Phenotype correlations</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Bardet- Biedl syndrome</td>
              <td align="left" rowspan="1" colspan="1">14 genes<xref ref-type="bibr" rid="CIT5">5</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS1<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 11q13 (23.2%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 12 (46.7%), 16 (16.7%), 15 (6.7%), 11 (6.7%), 4 (10%), 13 (3.3%), 10(3.3%), 8(3.3%), 1(3.3%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS2<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 16q21 (8.1%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 2 (30%), 1 (15%), 4 (15%), 8 (10%), 6 (10%), 14 (10%), 9 (5%), 15 (5%), 3 (5%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- BBS2, BBS3, and BBS4 correlated with characteristic ocular phenotypes.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">ARL6/BBS3<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 3p12-q13 (0.4%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS4<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 15q22.3-q23<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 13 (16.7%), 12 (16.7%), 8 (16.7%), 4 (16.7%), 3-4 (16.7%), 15 (8.3%), 7 (8.3%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">BBS4 correlated with extra digits.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS5<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 2q31 (0.4%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 7</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MKKS/BBS6<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 20p12 (5.8%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 3 (80.7%0, 6 (12.9%), 4 (3.2%), 5 (3.2%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">BBS2, BBS3, BBS4, and</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS7<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 4q27 (1.5%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 10 (50%), 6 (25%), 7 (25%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">BBS6 correlated with adult obesity.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">TTC8/BBS8<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 14q32.1 (1.2%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 10<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">BBS4 and BBS6 correlated with childhood obesity.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">B1/BBS9<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 7p14 (NK)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS10<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 12q21.2 (20%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">TRIM32/BBS11<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 9q31-q34.1 (&lt;0.4%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">BBS12<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 4q27 (5%)<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MKS/BBS13<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 17q23<xref ref-type="bibr" rid="CIT6">6</xref></td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MKS/BBS14<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 12q21.37</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Alstr&#xF6;m syndrome</td>
              <td align="left" rowspan="1" colspan="1">81 mutations<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td align="left" rowspan="1" colspan="1">2p1<xref ref-type="bibr" rid="CIT2">2</xref></td>
              <td align="left" rowspan="1" colspan="1">- 16 (40%)<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td align="left" rowspan="1" colspan="1">Exon 16 correlated with more severe disease, early RP, urologic dysfunction, dilated cardiomyopathy, and diabetes.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">ALS1</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">- 10 (23%)<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td align="left" rowspan="1" colspan="1">Axon 8 is correlated with renal disease.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">- 8 (21%)<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">- 6<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">- 12<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">- 17<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">- 18<xref ref-type="bibr" rid="CIT8">8</xref></td>
              <td rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>ARL6, ADP-ribosylation factor-like 6 gene; MKKS, McKusick-Kaufman syndrome; TTC8, Tetratricopeptide repeat domain 8 gene; TRIM32, Tripartite motif-containing 32 gene; MKS, Meckel-Gruber syndrome<xref ref-type="bibr" rid="CIT2">2</xref><xref ref-type="bibr" rid="CIT5">5</xref><xref ref-type="bibr" rid="CIT6">6</xref><xref ref-type="bibr" rid="CIT7">7</xref><xref ref-type="bibr" rid="CIT8">8</xref></p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Alstr&#xF6;m syndrome is a rare autosomal recessive genetic disease characterized by multi-organ dysfunction. It is clinically characterized by: (i) childhood obesity (95%), (ii) progressive cone-rod dystrophy ultimately leading to blindness with 90% of the patients becoming blind at the age of 16 years, (iii) sensorineural deafness (80%), (iv) dilated cardiomyopathy (60%), (v) heptic dysfunction (80%), (vi) renal insufficiency (50%), and (vii) endocrinological features.<xref ref-type="bibr" rid="CIT8">8</xref> It was first described in 1959 and 500 cases have been detected globally so far without any gender predilection.<xref ref-type="bibr" rid="CIT8">8</xref> It is now considered to be one of the class of genetic diseases known as ciliopathies in which the ciliary function of various cell types are affected, resulting in dysfunction of cells of renal tubules, sperm cells, and retinal cells, thereby producing the components of the syndrome.<xref ref-type="bibr" rid="CIT9">9</xref> The genetic disease is due to mutations in the <italic>ALMS1</italic> genes, of which 81 mutant genes have been detected so far (<xref ref-type="table" rid="T0003">Table 3</xref>).<xref ref-type="bibr" rid="CIT8">8</xref> As in Bardet-Biedl syndrome, and because of the wide-ranging and complex spectrum of phenotypes reported in the literature, Marshall et al adopted the diagnostic criteria for Alstr&#xF6;m syndrome as shown in <xref ref-type="table" rid="T0002">Table 2</xref>.<xref ref-type="bibr" rid="CIT10">10</xref> In adults, two major criteria and two minor criteria, or one major and four minor criteria are required for the clinical diagnosis of the syndrome. Hyperinsulinemia, which develops in early childhood, has been reported in 92% of individuals with ALM. Type 2 DM is diagnosed in 82% of the affected individuals older than 16 years of age and it is usually diagnosed in the second or third decade.<xref ref-type="bibr" rid="CIT8">8</xref><xref ref-type="bibr" rid="CIT11">11</xref> Hyperinsulinemia and hyperglycemia may be managed with a low carbohydrate diet, metformin, and rosiglitazone.<xref ref-type="bibr" rid="CIT12">12</xref><xref ref-type="bibr" rid="CIT13">13</xref> Cognitive function is preserved in Alstr&#xF6;m syndrome and polydactyly is not a feature, thus distinguishing it from Bardet-Biedl syndrome. Dilated cardiomyopathy can occur at any age, but it mainly occurs in infancy and is the main cause of mortality in that age group, whereas renal failure is the main cause of mortality in elder patients.<xref ref-type="bibr" rid="CIT14">14</xref> The life span of patients with Alstr&#xF6;m Syndrome rarely exceeds 40 years.<xref ref-type="bibr" rid="CIT13">13</xref></p>
      <p>Kearns-Sayre syndrome (KSS) is a rare mitochondrial disease with an as yet undetermined mode of inheritance. The true prevalence of this syndrome is unknown. The mitochondrial abnormalities involve mitochondrial DNA mutations, rearrangements, or deletions. It was first described in 1958 and several hundred cases have been diagnosed to date. Its labile clinical features make it rather difficult to diagnose.<xref ref-type="bibr" rid="CIT15">15</xref> It is characterized by: (i) external ophthalmoplegia, (ii) retinitis pigmentosa, (iii) cardiac conduction defects, (iv) a variety of endocrine abnormalities including short stature, gonadal failure, diabetes mellitus, thyroid disease, hyperaldostronism, hypomagnesemia, and (v) bone and dental abnormalities.<xref ref-type="bibr" rid="CIT16">16</xref> Diabetes mellitus was recorded in 13% of cases with KSS,<xref ref-type="bibr" rid="CIT16">16</xref> and was of the insulin-dependent type due to insulin deficiency.<xref ref-type="bibr" rid="CIT17">17</xref> KSS cases have high mortality rates which is directly attributable to the cardiovascular manifestations of this syndrome.<xref ref-type="bibr" rid="CIT18">18</xref></p>
      <p>Wolfram syndrome (WFS) is an autosomal recessive neurodegenerative disorder that predisposes individuals to the development of type 1 diabetes in association with progressive optic atrophy. It is an extremely rare condition with a prevalence of 1 in 770 000.<xref ref-type="bibr" rid="CIT19">19</xref> It is also known as DIDMOAD syndrome, the name being derived from diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. RP was reported in a few cases.<xref ref-type="bibr" rid="CIT20">20</xref> The genetic basis of the disease is due to mutations in the WFS1 gene, which has been postulated to be an endoplasmic reticulum calcium channel transporter in pancreatic &#x3B2;-cells and neurons.<xref ref-type="bibr" rid="CIT18">18</xref> Although diabetes and optic atrophy represent the minimal diagnostic criteria, other clinical characteristics include neurodegenerative disease involving the hypothalamus, brain stem, and the cerebellum. Diabetes is usually diagnosed in childhood and is of the nonautoimmune insulin-dependent type.<xref ref-type="bibr" rid="CIT21">21</xref> Deafness is not always a prominent component. Other abnormalities include dilated renal outflow tracts and primary gonadal atrophy. Death is usually due to respiratory failure from brain stem involvement<xref ref-type="bibr" rid="CIT22">22</xref> and renal failure.<xref ref-type="bibr" rid="CIT19">19</xref></p>
      <p>Of note, patients with DM and RP do not develop signs of diabetic retinopathy. The absence of diabetic retinopathy in RP was explained by the suggestion that the loss of photoreceptors reduced glycolysis and decreased the production of free radicals.<xref ref-type="bibr" rid="CIT23">23</xref> The combination of diabetes and blindness in these syndromes confers a high risk of foot ulceration. However, it has been reported that patients with Alstr&#xF6;m syndrome are protected from peripheral sensory neuropathy.<xref ref-type="bibr" rid="CIT24">24</xref></p>
      <p>In conclusion, we report two cases who had presented with retinitis pigmentosa and diabetes mellitus along with other overlapping clinical manifestations. Both cases were diagnosed based on clinical features into two different pleiotropically genetic disorders, namely, the Bardet-Biedl syndrome and Alstr&#xF6;m syndrome. Due to the overlapping clinical manifestations in these genetic disorders and the cost and time usually needed for genetic studies, clinical criteria can be used for diagnosis and as a guide for genetic mapping in affected individuals. Genetic studies are needed to confirm diagnosis, detect carriers in at-risk family members, and for genetic counseling and prenatal diagnosis.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="CIT1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hartong</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Berson</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Dryja</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Retinitis pigmentosa</article-title>
          <source>Lancet</source>
          <year>2006</year>
          <volume>368</volume>
          <fpage>1795</fpage>
          <lpage>809</lpage>
          <pub-id pub-id-type="pmid">17113430</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Beales</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Bardet-Biedl syndrome [internet]</article-title>
          <source>GeneReviews</source>
          <comment>Available from <ext-link ext-link-type="uri" xlink:href="http://www.geneclinics.org/profiles/all.html">http://www.geneclinics.org/profiles/all.html</ext-link>. [cited 2008 December</comment>
        </element-citation>
      </ref>
      <ref id="CIT3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Green</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Parfrey</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Harnett</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Farid</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The cardinal manifestations of Bardet-Biedl syndrome: A form of Laurence-Moon-Biedl syndrome</article-title>
          <source>N Eng J Med</source>
          <year>1989</year>
          <volume>321</volume>
          <fpage>1002</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CIT4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Dea</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Parfrey</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Harnett</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Hefferton</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The importance of renal impairment in the natural history of Bardet-Biedl syndrome</article-title>
          <source>Am J Kidney Dis</source>
          <year>1996</year>
          <volume>27</volume>
          <fpage>776</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">8651240</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel mutation in BBS7 gene causes Bardet-Biedl syndrome in a Chinese family</article-title>
          <source>Mol Vis</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>2304</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">19093007</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kytt&#xE4;l&#xE4;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tallila</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Salonen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kopra</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kohlschmidt</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Paavola-Sakki</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MKS1, encoding a component of the flagellar apparatus basal body proteome, is mutated in Meckel syndrome</article-title>
          <source>Nat Genet</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>155</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">16415886</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leitch</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Zaghloul</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Stoetzel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Diaz-Font</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rix</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome</article-title>
          <source>Nat Genet</source>
          <year>2008</year>
          <volume>40</volume>
          <fpage>443</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">18327255</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Charlton-Menys</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hegele</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Alstrom syndrome (OMIM 203800): A case report and literature review</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>49</fpage>
          <pub-id pub-id-type="pmid">18154657</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vega</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nelms</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gekakis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goodnow</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>McNamara</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A role for Alstr&#xF6;m syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence</article-title>
          <source>PLoS Genet</source>
          <year>2007</year>
          <volume>3</volume>
          <fpage>e8</fpage>
          <pub-id pub-id-type="pmid">17206865</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maffei</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Naggert</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Alstr&#xF6;m syndrome</article-title>
          <source>Eur J Hum Genet</source>
          <year>2007</year>
          <volume>15</volume>
          <fpage>1193</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">17940554</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Bronson</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Nordstrom</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Maffei</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Paisey</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New Alstr&#xF6;m syndrome phenotypes based on the evaluation of 182 cases</article-title>
          <source>Arch Intern Med</source>
          <year>2005</year>
          <volume>165</volume>
          <fpage>675</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">15795345</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paisey</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Hodge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Body fat distribution, serum glucose, lipid and insulin response to meals in Alstr&#xF6;m syndrome</article-title>
          <source>J Hum Nutr Diet</source>
          <year>2008</year>
          <volume>21</volume>
          <fpage>268</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">18477182</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sinha</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Bhangoo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Anhalt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maclaren</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>GB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of metformin and rosiglitazone in a prepubertal boy with Alstr&#xF6;m syndrome</article-title>
          <source>J Pediatr Endocrinol Metab</source>
          <year>2007</year>
          <volume>20</volume>
          <fpage>1045</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">18038714</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Russell-Eggitt</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Clayton</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Coffey</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kriss</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Alstr&#xF6;m syndrome: Report of 22 cases and literature review</article-title>
          <source>Ophthalmology</source>
          <year>1998</year>
          <volume>105</volume>
          <fpage>1274</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">9663233</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maceluch</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Niedziela</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The clinical diagnosis and molecular genetics of Kearns-sayre syndrome: a complex mitochondrial encephalomyopathy</article-title>
          <source>Pedriatr Endocrinol Rev</source>
          <year>2007</year>
          <volume>4</volume>
          <fpage>117</fpage>
          <lpage>37</lpage>
        </element-citation>
      </ref>
      <ref id="CIT16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harvey</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Barnett</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Endocrine dysfunction in Kearns-Sayre syndrome</article-title>
          <source>Clin Endocrinol</source>
          <year>1992</year>
          <volume>37</volume>
          <fpage>97</fpage>
          <lpage>103</lpage>
        </element-citation>
      </ref>
      <ref id="CIT17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isotani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fukumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Furukawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohsawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypoparathyroidism and insulin-dependent diabetes mellitus in a patient with Kearns-Sayre syndrome harbouring a mitochondrial DNA deletion</article-title>
          <source>Clin Endocrinol</source>
          <year>1996</year>
          <volume>45</volume>
          <fpage>637</fpage>
          <lpage>41</lpage>
        </element-citation>
      </ref>
      <ref id="CIT18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rheuban</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Ayres</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Sellers</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>DiMarco</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Near-fatal Kearns-Sayre syndrome: A case report and review of clinical manifestations</article-title>
          <source>Clin Pediatr</source>
          <year>1983</year>
          <volume>22</volume>
          <fpage>822</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="CIT19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>d'Annunzio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Minuto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>D'Amato</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>de Toni</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lombardo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pasquali</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Wolfram syndrome (diabetes insipidus, diabetes, optic atrophy, and deafness): Clinical and genetic study</article-title>
          <source>Diabetes Care</source>
          <year>2008</year>
          <volume>31</volume>
          <fpage>1743</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">18566338</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Till</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jarrah</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Ajlouni</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Ophthalmologic findings in fifteen patients with Wolfram syndrome</article-title>
          <source>Eur J Ophthalmol</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>84</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">12022290</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Crock</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Meldrum</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Phenotype-genotype correlations in a series of wolfram syndrome families</article-title>
          <source>Diabetes Care</source>
          <year>2004</year>
          <volume>27</volume>
          <fpage>2003</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15277431</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrett</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Bundey</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Wolfram (DIDMOAD) syndrome</article-title>
          <source>J Med Genet</source>
          <year>1997</year>
          <volume>34</volume>
          <fpage>838</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">9350817</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arden</surname>
              <given-names>GB</given-names>
            </name>
          </person-group>
          <article-title>The absence of diabetic retinopathy in patients with retinitis pigmentosa: Implications for pathophysiology and possible treatment</article-title>
          <source>Br J Ophthalmol</source>
          <year>2001</year>
          <volume>85</volume>
          <fpage>366</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">11222350</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paisey</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Paisey</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Bower</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Maffei</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shield</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protection from clinical peripheral sensory neuropathy in Alstrom syndrome in contrast to early onset type2 diabetes</article-title>
          <source>Diabetes Care</source>
          <year>2009</year>
          <volume>32</volume>
          <fpage>462</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">19092165</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
